Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease

被引：0
|
作者：
I.M. Blok
A.C.M.J. van Riel
M.J. Schuuring
M.G. Duffels
J.C. Vis
A.P.J. van Dijk
E.S. Hoendermis
B.J.M. Mulder
B.J. Bouma
机构：
[1] University of Amsterdam,Department of Cardiology, Academic Medical Centre
[2] ICIN,Department of Cardiology
[3] Netherlands Heart Institute,Department of Cardiology
[4] Radboud University Medical Centre,undefined
[5] University Medical Centre Groningen,undefined
来源：
Netherlands Heart Journal | 2015年 / 23卷
关键词：
Congenital heart defect; Pulmonary arterial hypertension; Quality of life; Serial; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：278 / 284
页数：6
相关论文
共 50 条
  • [31] Pulmonary hypertension in adult congenital heart disease
    Rodriguez-Lopez J.
    Current Treatment Options in Cardiovascular Medicine, 2014, 16 (8)
  • [32] Pulmonary Hypertension/Pulmonary arterial Hypertension in congenital Heart Disease and Therapy of pulmonary arterial Hypertension in Children
    Gorenflo, M.
    Apitz, C.
    Miera, O.
    Stiller, B.
    Schranz, D.
    Berger, F.
    Hager, A.
    Kaemmerer, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S166 - S170
  • [33] Functional parameters or biomarkers: which best predicts prognosis in adults with pulmonary arterial hypertension due to congenital heart disease?
    Blok, I. M.
    Van Riel, A. C. M. J.
    Schuuring, M. J.
    De Bruin-Bon, R. H. A. C. M.
    Van Dijk, A. P. J.
    Hoendermis, E. S.
    Zwinderman, A. H.
    Mulder, B. J. M.
    Bouma, B. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 458 - 459
  • [34] Exercise ventilatory reserve predicts survival in adult congenital heart disease associated pulmonary arterial hypertension with Eisenmenger physiology
    Samaranayake, Chinthaka B.
    Mcniven, Ruth
    Kempny, Aleksander
    Harries, Carl
    Price, Laura C.
    Gatzoulis, Michael
    Dimopoulos, Konstantinos
    Wort, Stephen J.
    Mccabe, Colm
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2022, 7
  • [35] lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease
    Yang, Qi
    Fan, Wei
    Lai, Banghui
    Liao, Bin
    Deng, Mingbin
    PLOS ONE, 2023, 18 (03):
  • [36] lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease
    Yang, Qi
    Fan, Wei
    Lai, Banghui
    Liao, Bin
    Deng, Mingbin
    PLOS BIOLOGY, 2023, 21 (03)
  • [37] Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions
    Blok, Ilja M.
    Annelieke, C. M.
    van Riel, J.
    Mulder, Barbara J. M.
    Bouma, Berto J.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (12) : 1377 - 1392
  • [38] Bosentan therapy for pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease: A multicenter cooperation
    Schulze-Neick, I
    Gilbert, N
    Ewert, R
    Witt, C
    Gruenig, E
    Olschewski, H
    Borst, MM
    Hoeper, MM
    Lange, PE
    CIRCULATION, 2004, 110 (17) : 652 - 652
  • [39] Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease
    Benza, RL
    Rayburn, BK
    Tallaj, JA
    Coffey, CS
    Pinderski, LJ
    Parnoukian, SV
    Bourge, RC
    CHEST, 2006, 129 (04) : 1009 - 1015
  • [40] Rehabilitation Program in Adult Congenital Heart Disease Patients with Pulmonary Hypertension
    Martinez-Quintana, Efren
    Miranda-Calderin, Guillermo
    Ugarte-Lopetegui, Arantza
    Rodriguez-Gonzalez, Fayna
    CONGENITAL HEART DISEASE, 2010, 5 (01) : 44 - 50
12345